Globe Newswire » trang 13 » Trang Công Nghệ | Trangcongnghe.vn

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

Globenewswire -

Clash Royale Searches for Its First-Ever Rage Emote, As New Research Finds 85% of Players Who Rage Quit Come Back Enjoying the Game More

Clash Royale Searches for Its First-Ever Rage Emote, As New Research Finds 85% of Players Who Rage Quit Come Back Enjoying the Game More

Globenewswire -

12B SPORTS and VR46 Racing Team Bring Sung Kang into the World of MotoGP

12B SPORTS and VR46 Racing Team Bring Sung Kang into the World of MotoGP

Globenewswire -

12B SPORTS và VR46 Racing Team đưa Sung Kang đến gần hơn với thế giới MotoGP

12B SPORTS và VR46 Racing Team đưa Sung Kang đến gần hơn với thế giới MotoGP

Globenewswire -

Viet Nam Is Asia Pacific's Most Improved Government Since 2021, the Chandler Index Finds

Viet Nam Is Asia Pacific's Most Improved Government Since 2021, the Chandler Index Finds

Globenewswire -

CCTE Engages Kinectrics to Independently Review ANEEL Fuel Qualification Program

CCTE Engages Kinectrics to Independently Review ANEEL Fuel Qualification Program

Globenewswire -

Templafy launches free document agent in Microsoft Marketplace

Templafy launches free document agent in Microsoft Marketplace

Globenewswire -

XEM THÊM TIN MỚI